HCW Biologics(HCWB) - 2025 Q3 - Quarterly Results

EXHIBIT 99.1 HCW Biologics Reports Third Quarter 2025 Business Highlights and Financial Results Miramar, FL – November 14, 2025 – HCW Biologics Inc. (the "Company" or "HCW Biologics") (NASDAQ: HCWB), a clinical-stage biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen healthspan by disrupting the link between inflammation and diseases, today reported financial results and recent business highlights for its three months ended September 30, 2025. The Company antic ...